New Research From Oregon State University Could Help People With Alzheimer’s And Parkinson’s
The research is 10 years in the making and scientists discovered a new class of potential drug targets.
Alzheimer's
Inside The Tactical Tug Of War Over The Controversial Alzheimer’s Drug
Pharmaceutical industry and patients representatives want to stop restricting Medicare funding for a controversial Alzheimer’s drug. Critics say it should never have been approved.
New Alzheimer’s Drug Manufacturer Launches Controversial Campaign
Facing a host of challenges, Aduhelm’s makers are running an educational campaign directed at consumers who are worried about whether their forgetfulness is a sign of disease.
Why We May Never Know Whether The $56,000-A-Year Alzheimer’s Drug Actually Works
Scientists may have to wait many years to find out whether Aduhelm is actually effective because the drug was approved using FDA's accelerated pathway.
Paying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?
Prescriptions for a controversial new drug for Alzheimer's could run $56 billion a year, putting a significant financial burden on Medicare, the health insurance for the elderly.
How Soon Is Soon Enough To Learn You Have Alzheimer’s?
Researchers are making progress on measuring signs of Alzheimer’s in blood that might lead to an inexpensive, noninvasive and early diagnosis tool.
Jose Belardo of Lansing, Kan., spent most of his career in the U.S. Public Health Service. He worked on the front lines of disasters in such places as Haiti, Colombia, Nicaragua and the Dominican Republic.
Finances Come First, Following Alzheimer's Diagnosis
More than 120 people who care for Alzheimer’s patients held a conference in Wilsonville Wednesday. They learned the first thing families should do when a loved one gets dementia.
Wyden Urges Funding for Alzheimer’s Research
This country spends less than $600 million a year on Alzheimer’s disease and dementia research.
Senator Ron Wyden has joined his colleagues, urging the Senate Appropriations Committee to beef up research funding for Alzheimer’s disease.
Currently the NIH spends about $585 million on Alzheimer’s disease and dementia research, compared to $450 million in fiscal year 2011.
A Heart-Healthy Diet May Also Be a Brain-Healthy Diet, OHSU Researcher Says
Dr. Joseph Quinn says his research preventing strokes may also reduce the risk of Alzheimer's and other forms of dementia
Alzheimer's disease ranks among American's most-feared terminal illnesses – and may kill far more people than previously believed, according to research showing Alzheimer's is a factor in deaths such as pneumonia, choking
